| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11095-005-4589-9 |
| P698 | PubMed publication ID | 15948038 |
| P50 | author | Lorenz Meinel | Q37829415 |
| P2093 | author name string | Hans P Merkle | |
| Bruno Gander | |||
| Esther Wenk | |||
| Annette Koch | |||
| Vera Luginbuehl | |||
| P2860 | cites work | Induction of angiogenesis by implantation of encapsulated primary myoblasts expressing vascular endothelial growth factor | Q74210294 |
| Extensive in vivo angiogenesis following controlled release of human vascular endothelial cell growth factor: implications for tissue engineering and wound healing | Q74329802 | ||
| Release from alginate enhances the biological activity of vascular endothelial growth factor | Q77708503 | ||
| Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing | Q77716685 | ||
| Degradation of calcium phosphate ceramics | Q77975389 | ||
| Purification of somatomedin-C from human plasma: chemical and biological properties, partial sequence analysis, and relationship to other somatomedins | Q24302548 | ||
| Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties | Q28288698 | ||
| Matrix deposition by a calcifying human osteogenic sarcoma cell line (SAOS-2) | Q28292954 | ||
| Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering: part 1. Structure, gelation rate and mechanical properties | Q32060641 | ||
| Protein release from alginate matrices | Q33933226 | ||
| Injectable gels for tissue engineering | Q34334329 | ||
| Hydrogels for biomedical applications | Q34469979 | ||
| Induction of cytokine production from human monocytes stimulated with alginate | Q34968426 | ||
| Bioactive glasses for in situ tissue regeneration | Q35814269 | ||
| Growth factors in bone | Q36748632 | ||
| Skeletal repair by in situ formation of the mineral phase of bone | Q38505425 | ||
| Isoelectric points of proteins: A table | Q38569840 | ||
| The role of the CaCl2-guluronic acid interaction on alginate encapsulated betaTC3 cells | Q40594110 | ||
| Insulin-like growth factor I (IGF-I) stimulates proliferation but also increases caspase-3 activity, Annexin-V binding, and DNA-fragmentation in human MG63 osteosarcoma cells: co-activation of pro- and anti-apoptotic pathways by IGF-I. | Q40601506 | ||
| Alginate hydrogels as synthetic extracellular matrix materials | Q40978578 | ||
| Insulinlike growth factor I: a potent mitogen for human osteogenic sarcoma | Q41198982 | ||
| Mitogenic action of insulin-like growth factor-I on human osteosarcoma MG-63 cells and rat osteoblasts maintained in situ: the role of glucose-6-phosphate dehydrogenase | Q41538011 | ||
| Angiogenesis monitored by perfusion with a space-filling microbead suspension | Q41753505 | ||
| Insulin-like growth factors I and II: some biological actions and receptor binding characteristics of two purified constituents of nonsuppressible insulin-like activity of human serum | Q41850305 | ||
| Are MG-63 and HOS TE85 human osteosarcoma cell lines representative models of the osteoblastic phenotype? | Q42489753 | ||
| Characterization of a human osteoblastic osteosarcoma cell line (SAOS-2) with high bone alkaline phosphatase activity | Q42502221 | ||
| The osteoblast-like differentiated phenotype of a variant of MG-63 osteosarcoma cell line correlated with altered adhesive properties | Q42814429 | ||
| Development of an injectable, in situ crosslinkable, degradable polymeric carrier for osteogenic cell populations. Part 1. Encapsulation of marrow stromal osteoblasts in surface crosslinked gelatin microparticles | Q44130319 | ||
| Designing alginate hydrogels to maintain viability of immobilized cells | Q44496888 | ||
| Localized insulin-like growth factor I delivery to enhance new bone formation | Q44608130 | ||
| Effects of ascorbic acid and ascorbic acid 2-phosphate, a long-acting vitamin C derivative, on the proliferation and differentiation of human osteoblast-like cells | Q44862512 | ||
| Gene expression of insulin-like growth factors I and II in rat membranous osteotomy healing. | Q45858393 | ||
| Delivery of osteoinductive growth factors from degradable PEG hydrogels influences osteoblast differentiation and mineralization | Q46287978 | ||
| The effect of poly-L-lactic acid with parallel surface micro groove on osteoblast-like cells in vitro | Q46290960 | ||
| Sustained delivery of vascular endothelial growth factor with alginate beads | Q47665706 | ||
| Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. | Q51088335 | ||
| Regulating bone formation via controlled scaffold degradation. | Q51807677 | ||
| The mechanical properties of human tibial trabecular bone as a function of metaphyseal location | Q71198724 | ||
| Recruitment of tissue resident cells to hydrogel composites: in vivo response to implant materials | Q72873213 | ||
| Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial | Q73142282 | ||
| Stabilizing insulin-like growth factor-I in poly(D,L-lactide-co-glycolide) microspheres | Q73413373 | ||
| The effects of calcium phosphate particles on the growth of osteoblasts | Q73877160 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 940-950 | |
| P577 | publication date | 2005-06-08 | |
| P1433 | published in | Pharmaceutical Research | Q7180737 |
| P1476 | title | Insulin-like growth factor I-releasing alginate-tricalciumphosphate composites for bone regeneration | |
| P478 | volume | 22 |
| Q38207599 | Adipose mesenchymal stem cells in the field of bone tissue engineering |
| Q37143919 | Bioengineering approaches to controlled protein delivery |
| Q38189789 | Drug delivery using composite scaffolds in the context of bone tissue engineering |
| Q37590937 | Enhanced in vitro osteoblast differentiation on TiO2 scaffold coated with alginate hydrogel containing simvastatin. |
| Q30488316 | Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering |
| Q38160358 | Natural and synthetic biomaterials for controlled drug delivery |
| Q36782519 | Natural origin biodegradable systems in tissue engineering and regenerative medicine: present status and some moving trends |
| Q33709375 | Neurotherapeutic activity of the recombinant heat shock protein Hsp70 in a model of focal cerebral ischemia in rats |
| Q37876388 | Polymer-based microparticles in tissue engineering and regenerative medicine |
| Q37035579 | Silk constructs for delivery of musculoskeletal therapeutics. |
| Q37071721 | Synthesis of and in vitro and in vivo evaluation of a novel TGF-β1-SF-CS three-dimensional scaffold for bone tissue engineering |
Search more.